Islamic State Supporters React Angrily to Trump’s

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone john1234 #17296
236
Islamic State Supporters React Angrily to Trump’s Temporary Refugee Halt



Islamic State sympathizers and militants predictably reacted angrily to President Donald Trump’s temporary halt on refugees while the government revamps its flawed security screening process.

Breitbart Jerusalem obtained access to correspondence posted in a closed chat group that utilizes the encrypted Telegram messaging service. The chat group serves as an internal Twitter of sorts for IS jihadists and sympathizers, and it has been used in the past to issue IS communications.

“The madman Trump is still ignorant of politics, science and culture,” IS supporter Abu Maslama wrote to his associates on the Telegram app. “That Islam-hating Crusader prevents Muslims from entering America. That failed Nazi thinks that this will stop the mujahedeen from striking his country. Doesn’t he understand that his country will implode? When that happens, he’ll panic and backpedal on his Islam-hating policies.

ABU-MUSALAMA-TELEG.jpg


Maslama offered no explanation as to how the U.S. will purportedly implode from implementing stricter security screening procedures aimed at keeping terrorists out of the country. He also falsely claimed that Trump was preventing Muslims from entering the country. In actuality, Trump’s executive order halts visas for 90 days for “immigrants and non-immigrants” from Syria, Somalia, Sudan, Libya, Yemen, Iran, and Iraq. The order further suspended the entry of all refugees for 120 days, indefinitely blocked Syrian refugees from entering and lowered the ceiling to 50,000 for refugees allowed to enter the U.S. during Fiscal Year 2017.

Meanwhile, Telegram user Omra Alfarouq, another IS supporter, wrote: “The decisions made by that fool (Trump) will drag America and its supporters into a war against each other that will be sparked by the mujahedeen, who will take advantage of it to settle in.”

Utilizing racist language, Alfarouq continued, “The confrontations with the blacks that started under the donkey Obama will repeat itself, but this time in a much broader way among the Americans. And the Muslims will exploit these confrontations to strike in the heart of the infidel country. Don’t think victory will come on its own. It will emanate from their stupidity and their criminal acts that attest to their hatred of Islam. Allah in his wisdom will strengthen the mujahedeen and lead them to victory.”

An IS supporter who messages under the name “IS Will Live Forever” wrote: “Trump and (Vladimir) Putin the Crusaders’ hatred for Islam is conspicuous and their policies only prove it. The war against the Crusaders began and will end with their defeat. We are at the end of times, and what times they are – the times of the oppressed mujahedeen on the face of the earth. The wisdom of Allah will allow the mujahedeen and the oppressed to rise up and cut off the heads of Crusaders… and whoever supports them among those who falsely claim to be Muslim.”

Last November, a car-ramming and mass stabbing attack was carried out at Ohio State University by Somali refugee Abdul Razak Ali Artan, who was reportedly inspired by IS.

In 2013, ABC News first revealed that two years earlier, the State Department imposed a freeze over the processing of Iraqi refugees for six months. The halt was the result of the discovery of two al-Qaida members admitted as refugees from Iraq who were living in Bowling Green, Kentucky and who had admitted to targeting U.S. troops in Iraq. The network at the time also cited FBI agents conceding that “several dozen suspected terrorist bombmakers, including some believed to have targeted American troops, may have m
istakenly been allowed to move to the United States as war refugees.”
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 545

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 791

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 526

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 112

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 129

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 188

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 190

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 138

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 40

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 309

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading

Top 5 Most Recently Viewed Articles

Volvo Ends LiDAR Partnership: What This Means for LAZR Stock

Updated Category News Views 315

Volvo's Shift Away from LiDAR Technology Recently, the Swedish automaker Volvo announced its decision to cease its partnership with Luminar Technologies Inc. (NASDAQ: LAZR). This bold move has caught the attention of the automotive industry, especially those tracking advancements in autonomous vehicle technology. By not integrating LiDAR technology into its forthcoming...

Continue Reading
Samsung and Xiaomi Face Antitrust Findings in India Market

Updated Category News Views 157

Samsung and Xiaomi Face Antitrust Investigation in India Samsung, Xiaomi, and various other smartphone manufacturers are under serious scrutiny for allegedly colluding with major e-commerce platforms in India, undermining fair market practices. The Competition Commission of India (CCI) has gathered evidence that suggests these companies coordinated with Amazon and...

Continue Reading
Bonnie Navin Honored as Top 25 Medical Malpractice Attorney

Updated Category News Views 164

Bonnie Navin Attributes and Accolades Bonnie Navin of Rubenstein Law has recently earned a significant honor by being selected as a member of the Medical Malpractice Trial Lawyers Association - Top 25. This elite recognition is awarded to the most distinguished attorneys specializing in medical malpractice across the nation, and it showcases Navin's exceptional skill and...

Continue Reading
Top Dividend Stocks for Long-Term Passive Income Investors

Updated Category News Views 99

Success in the business world has never been a cakewalk. Many new ventures stumble within a decade, and only a handful manage to stay afloat while also boasting a robust and growing dividend program. Companies that consistently dish out dividends reflect financial health, but there’s more to the story. Take Abbott Laboratories (NYSE: ABT) and Johnson & Johnson (NYSE:...

Continue Reading
Cathie Wood Predicts Deflationary Boom Amid Market Decline

Updated Category News Views 404

Cathie Wood's Deflationary Boom Forecast Amid Market Turbulence CEO of Ark Funds, Cathie Wood, has made bold predictions regarding a potential "deflationary boom" despite significant losses in the stock market. Recent trading sessions saw renowned tech stocks, collectively known as the Magnificent Seven, lose about $780 billion in market capitalization in a single day,...

Continue Reading